Enteric Coated, Low-Strength Pancrelipase Formulations

Patent No. EP2818160 (titled "Enteric Coated, Low-Strength Pancrelipase Formulations") was filed by Allergan Pharmaceuticals on Sep 30, 2011. The application was issued on Nov 8, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREAug 8, 2018MATHYS & SQUIRE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2818160

ALLERGAN PHARMACEUTICALS
Application Number
EP14176579A
Filing Date
Sep 30, 2011
Status
Revoked
Jul 14, 2023
Publication Date
Nov 8, 2017